Kura Oncology president and CEO buys $1.5M of KURA stock
Kura Oncology
- $1,504,765.01[1]
- 200,000[1]
Kura Oncology (KURA) president and CEO Troy Edward Wilson bought $1,504,765.01 of company stock on Nov 13, 2026, a Form 4 filed with the SEC on Nov 17, 2026 shows. The filing reports a purchase (code P), submitted 4 days after the trade.[1]
| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Troy Edward Wilson | 2026-11-13 | P | Purchase | 98,881 | $7.63 | 534,337 | 4 days |
| Common Stock | Troy Edward Wilson | 2026-11-16 | P | Purchase | 101,119 | $7.42 | 635,456 | 4 days |
What does the Form 4 show?
It lists 2 transactions for 200,000 shares, at an average $7.52 a share. Troy Edward Wilson owned 635,456 shares after the last one, 45.9% more than before the first purchase.[1]
What else has the filing history shown?
What does this filing not show?
A Form 4 reports one set of trades, filed 4 days after the trade. It does not show why Troy Edward Wilson traded or what else they own.[1]
KURA insider trading activity
In open-market trades dated in the last 90 days, 1 insider bought $2.7M and 6 insiders sold $1.7M, $1.4M of it under preset trading plans, per Form 4 filings.
- Troy Edward Wilson (President and CEO) bought 300,000 shares for $2.7M, last filed Nov 17.
- Teresa Brophy Bair (Chief Legal Officer) sold 39,929 shares for $486K under a preset plan, last filed Sep 29.
- Mollie Leoni (Chief Medical Officer) sold 41,250 shares for $440K under a preset plan, last filed Sep 29.
- Brian T. Powl (Chief Commercial Officer) sold 36,795 shares for $397K under a preset plan, last filed Sep 29.
- Francis Burrows (Chief Scientific Officer) sold 20,726 shares for $225K, last filed Sep 25.
Get KURA alerts
Set a KURA price alert, or get one when a fund, insider or politician you follow trades.